Company: SYRA
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001493152-25-022023
Chunk: 1

Company: Syra Health Corp
Filing Date: 2025-11-12
Form: 10-Q
Item: Item 1
Chunk 1
---
169 and 8,979,204 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively 
     11,339  
     8,979 
  
    Convertible class B common stock, $0.001 par value, 5,000,000 shares authorized, 600,000 and 833,334 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively 
     600  
     833 
  
    Common stock, value 
     600  
     833 

    Additional paid-in capital 
     11,783,405  
     11,692,952 
  
    Accumulated deficit 
     (9,585,956) 
     (8,824,193)
  
    Total stockholders’ equity 
     2,209,388  
     2,878,571 

    Total liabilities and stockholders’ equity 
    $3,263,217  
    $3,679,332 

See
accompanying notes to condensed unaudited financial statements.

F-1

SYRA
HEALTH CORP.

CONDENSED
STATEMENTS OF OPERATIONS

(Unaudited)

    2025  
    2024  
    2025 
    2024

    For the Three Months Ended  
    For the Nine Months Ended

    2025  
    2024  
    2025 
    2024

    Net revenues 
    $1,687,971  
    $2,253,336  
    $5,491,944 
     
    $5,975,357

    Cost of services 
     1,133,430  
     1,585,038  
     3,595,352 
     
     4,657,273

    Gross profit 
     554,541  
     668,298  
     1,896,592 
     
     1,318,084

    Operating expenses: 

    Salaries and benefits 
     336,390  
     594,738  
     1,169,951 
     
     2,178,105

    Professional services 
     191,726  
     153,803  
     580,691